Key points are not available for this paper at this time.
Although breast cancer survivors are at risk for cardiovascular disease (CVD) from treatment late effects, evidence to inform long-term and age-specific cardiovascular surveillance recommendations is lacking.
Vo et al. (Wed,) studied this question.